loadpatents
name:-0.05085301399231
name:-0.023969888687134
name:-0.0090630054473877
Verner; Erik J. Patent Filings

Verner; Erik J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Verner; Erik J..The latest application filed is for "inhibitors of bruton's tyrosine kinase".

Company Profile
8.25.47
  • Verner; Erik J. - Belmont CA
  • Verner; Erik J. - San Mateo CA
  • Verner; Erik J. - US
  • Verner, Erik J. - Foster City CA
  • Verner; Erik J. - San Diego CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Inhibitors of Bruton's Tyrosine Kinase
App 20220213106 - Buggy; Joseph J. ;   et al.
2022-07-07
Synthesis Of A Bruton's Tyrosine Kinase Inhibitor
App 20220098200 - Ben Haim; Cyril ;   et al.
2022-03-31
Inhibitors Of Bruton's Tyrosine Kinase
App 20220008424 - Honigberg; Lee ;   et al.
2022-01-13
Synthesis Of A Bruton's Tyrosine Kinase Inhibitor
App 20200347064 - Ben Haim; Cyril ;   et al.
2020-11-05
Inhibitors Of Bruton's Tyrosine Kinase For The Treatment Of Solid Tumors
App 20200289515 - Honigberg; Lee ;   et al.
2020-09-17
Inhibitors Of Bruton's Tyrosine Kinase
App 20200108072 - Honigberg; Lee ;   et al.
2020-04-09
Inhibitors Of Brutons Tyrosine Kinase
App 20200055859 - Buggy; Joseph J. ;   et al.
2020-02-20
Synthesis Of A Bruton's Tyrosine Kinase Inhibitor
App 20190367518 - Ben Haim; Cyril ;   et al.
2019-12-05
Formulations Of Histone Deacetylase Inhibitor And Uses Thereof
App 20190184196 - Loury; David J. ;   et al.
2019-06-20
Formulations of histone deacetylase inhibitor and uses thereof
Grant 10,105,552 - Loury , et al. October 23, 2
2018-10-23
Inhibitors Of Bruton's Tyrosine Kinase
App 20180085372 - HONIGBERG; LEE ;   et al.
2018-03-29
Synthesis Of A Bruton?s Tyrosine Kinase Inhibitor
App 20180009814 - Benhaim; Cyril ;   et al.
2018-01-11
Inhibitors Of Bruton's Tyrosine Kinase
App 20170362246 - Buggy; Joseph J. ;   et al.
2017-12-21
Formulations Of Histone Deacetylase Inhibitor And Uses Thereof
App 20170333731 - Loury; David J. ;   et al.
2017-11-23
Inhibitors of Bruton's Tyrosine Kinase for the Treatment of Solid Tumors
App 20170246169 - Honigberg; Lee ;   et al.
2017-08-31
Inhibitors Of Bruton's Tyrosine Kinase
App 20170007611 - Honigberg; Lee ;   et al.
2017-01-12
Formulations of histone deacetylase inhibitor in combination with bendamustine and uses thereof
Grant 9,492,423 - Loury , et al. November 15, 2
2016-11-15
Formulations of histone deacetylase inhibitor and uses therof
Grant 9,403,032 - Loury , et al. August 2, 2
2016-08-02
Hydroxamates as therapeutic agents
Grant 9,186,347 - Verner , et al. November 17, 2
2015-11-17
Novel Hydroxamates As Therapeutic Agents
App 20150320718 - VERNER; Erik J. ;   et al.
2015-11-12
Inhibitors of bruton's tyrosine kinase
Grant 9,139,591 - Honigberg , et al. September 22, 2
2015-09-22
Inhibitors of Bruton'S tyrosine kinase
Grant 9,079,908 - Honigberg , et al. July 14, 2
2015-07-14
Formulations Of Histone Deacetylase Inhibitor And Uses Therof
App 20150164854 - LOURY; David J. ;   et al.
2015-06-18
Inhibitors of bruton's tyrosine kinase
Grant 8,940,750 - Honigberg , et al. January 27, 2
2015-01-27
Formulations Of Histone Deacetylase Inhibitor In Combination With Bendamustine And Uses Thereof
App 20140341989 - Loury; David J. ;   et al.
2014-11-20
Novel Hydroxamates As Therapeutic Agents
App 20140301976 - VERNER; Erik J. ;   et al.
2014-10-09
Hydroxamates as therapeutic agents
Grant 8,779,171 - Verner , et al. July 15, 2
2014-07-15
Formulations Of Histone Deacetylase Inhibitor And Uses Therof
App 20140057862 - LOURY; David J. ;   et al.
2014-02-27
Formulations of histone deacetylase inhibitor and uses thereof
Grant 8,603,521 - Loury , et al. December 10, 2
2013-12-10
Novel Hydroxamates As Therapeutic Agents
App 20130142758 - VERNER; Erik J. ;   et al.
2013-06-06
Hydroxamates as therapeutic agents
Grant 8,389,570 - Verner , et al. March 5, 2
2013-03-05
Inhibitors Of Bruton's Tyrosine Kinase
App 20130035334 - HONIGBERG; Lee ;   et al.
2013-02-07
Inhibitors Of Bruton's Tyrosine Kinase
App 20120329130 - Honigberg; Lee ;   et al.
2012-12-27
Inhibitors Of Bruton's Tyrosine Kinase
App 20120296089 - Honigberg; Lee ;   et al.
2012-11-22
Inhibitors Of Bruton's Tyrosine Kinase
App 20120277225 - Honigberg; Lee ;   et al.
2012-11-01
Inhibitors Of Bruton's Tyrosine Kinase
App 20120277255 - Honigberg; Lee ;   et al.
2012-11-01
Inhibitors Of Il2-inducible T-cell Kinase
App 20120202264 - Honigberg; Lee ;   et al.
2012-08-09
Inhibitors of BMX non-receptor tyrosine kinase
App 20120184013 - Honigberg; Lee ;   et al.
2012-07-19
Inhibitors Of Bruton's Tyrosine Kinase
App 20120184567 - Honigberg; Lee ;   et al.
2012-07-19
Inhibitors Of Bruton's Tyrosine Kinase
App 20120178753 - Honigberg; Lee ;   et al.
2012-07-12
Inhibitors Of B Lymphocyte Kinase
App 20120165328 - Honigberg; Lee ;   et al.
2012-06-28
Inhibitors Of Bruton's Tyrosine Kinase
App 20120101113 - Honigberg; Lee ;   et al.
2012-04-26
Inhibitors Of Bruton's Tyrosine Kinase
App 20120101114 - Honigberg; Lee ;   et al.
2012-04-26
Novel Hydroxamates As Therapeutic Agents
App 20120064032 - Verner; Erik J. ;   et al.
2012-03-15
Inhibitors Of Bruton's Tyrosine Kinase
App 20120065201 - Honigberg; Lee ;   et al.
2012-03-15
Formulations Of Histone Deacetylase Inhibitor And Uses Thereof
App 20110311624 - LOURY; David J. ;   et al.
2011-12-22
Hydroxamates as therapeutic agents
Grant 8,026,371 - Verner , et al. September 27, 2
2011-09-27
Novel Hydroxamates As Therapeutic Agents
App 20110021528 - Verner; Erik J. ;   et al.
2011-01-27
Hydroxamates as therapeutic agents
Grant 7,834,054 - Verner , et al. November 16, 2
2010-11-16
Inhibitors Of Bruton's Tyrosine Kinase
App 20100254905 - Honigberg; Lee ;   et al.
2010-10-07
Novel Hydroxamates As Therapeutic Agents
App 20090220454 - Verner; Erik J. ;   et al.
2009-09-03
Hydroxamates as therapeutic agents
Grant 7,517,988 - Verner , et al. April 14, 2
2009-04-14
Hydroxamates as therapeutic agents
Grant 7,482,466 - Verner , et al. January 27, 2
2009-01-27
Novel Hydroxamates As Therapeutic Agents
App 20080255214 - Verner; Erik J. ;   et al.
2008-10-16
Novel Hydroxamates As Therapeutic Agents
App 20080255221 - Verner; Erik J. ;   et al.
2008-10-16
Hydroxamates as therapeutic agents
Grant 7,420,089 - Verner , et al. September 2, 2
2008-09-02
Novel Hydroxamates As Therapeutic Agents
App 20080004331 - Verner; Erik J. ;   et al.
2008-01-03
Novel Hydroxamates As Therapeutic Agents
App 20070293540 - Verner; Erik J. ;   et al.
2007-12-20
Mesylate salt of 5-(2-dimethylaminoethoxy)-1H-indole-2-carboxylic acid [3-(4-hydroxycarbamoylphenyl)prop-2-ynyl]amide
App 20070105939 - Verner; Erik J.
2007-05-10
Novel hydroxamates as therapeutic agents
App 20050187261 - Verner, Erik J. ;   et al.
2005-08-25
(Hetero)aryl-bicyclic heteroaryl derivatives, their preparation and their use as protease inhibitors
Grant 6,867,200 - Allen , et al. March 15, 2
2005-03-15
Thienyl-, furyl- and pyrrolyl sulfonamides and derivatives thereof that modulate the activity of endothelin
Grant 5,594,021 - Chan , et al. January 14, 1
1997-01-14
Thiophenyl-, furyl-and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin
Grant 5,591,761 - Chan , et al. * January 7, 1
1997-01-07
Sulfonamides and derivatives thereof that modulate the activity of endothelin
Grant 5,571,821 - Chan , et al. November 5, 1
1996-11-05
Company Registrations
SEC0001664488Verner Erik J.

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed